chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I felt itchy in my forehead/Itchy; had a rash; Allergic reaction; This is a spontaneous report from a contactable consumer (patient).   A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0217 (not appropriately clarified)), via an unspecified route of administration on 05Jul2021 at the age of 67-year-old as dose 1, single for covid-19 immunisation. Medical history included high blood pressure, prediabetes, bone disorder (calcium for bones) and high cholesterol. patient was allergic to keflex and peanut. Concomitant medication included hydrochlorothiazide (MICROZIDE)- (daily being 3 to 4 years), lisinopril, vitamins all taken for an unspecified indication start and stop date were not reported; pravastatin before going to bed taken for blood cholesterol increased, start and stop date were not reported; calcium taken for bone disorder, start and stop date were not reported. On 06Jul2021 morning, patient felt itchy on her forehead. Patient had some allergies on forehead and it wasn't a severe allergic reaction, just itchy and then it had a rash. Patient contact her doctor in primacy care and doctor advised her to take the medicine for the allergy and  she took Benadryl (25 milligrams), just 2 pills, one in the morning (06Jul2021) and one on the 07Jul2021 because the allergy continues to have been there (not clarified further). Patient felt really good and was fine after the treatment. Patient was have her next dose on 26th Monday. She wanted to know if she can go and take second dose, or is there something I have to do. On unspecified date in 2021, patient underwent lab tests and procedures which included blood cholesterol: cholesterol was little high and hemoglobin was so good and fine. The outcome of the events was recovering.
Patient states the evening of vaccines she experienced pain in hands and feet. A day or 2 later noticed swelling in hands, feet and ankles. She saw MD 10 days after vaccines and was given prednisone. She says MD thinks it's a reaction to BOOSTRIX or to RITALIN, which she recently began taking. Also noticed increased use of inhaler but chest x-ray clean.
Very bad headache 11/19/2022 fever; slept all day; was hungry with no appetite. Cough remains
Pt recv vax in 10/97; post vax pt exp serum sickness w/ synovitis & arthropathy, joint swelling, edema of extremities,arthritis of wrists/ankles/knees, rash, fatigue, fever & scaly rash on dorsal of left foot
Pt recvd 2 doses of Engerix-B & 29JUL92 devel itching on top of head, tops of feet, & arms; no visible lesions;
This spontaneous report as received from a nurse refers to an 11 years old patient (unknown gender). No concurrent condition, medical history or allergy/drug reactions were reported. On 10-APR-2015, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) GARDASIL injection, dose number 1, lot #K004204, exp. date: 12-JAN-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Pediarix given, Infanrix ordered. No symptoms reported; no treatment needed. Doctor notified.
The pt is experiencing fever, a sore and achy arm from the elbow upward, pain in the side and back (also experienced with COVID vaccine), swollen lymph node and neck pain.
Patient received flu shot in left arm on 10/12/15. He called pharmacy on 10/22/15 and stated that he noticed hives on his arm, shoulder, back, and waist on 10/16/15. He reported to have have for 4-5 days. Patient reported hives to not be overly bothersome. I recommended Benadryl for any itching and to see his primary care physician.
Occupational exposure; A spontaneous report was received from a nurse, who is a patient of unspecified age and gender, who administered Moderna's COVID-19 vaccine (mRNA-1273) and experienced occupational exposure (Occupational exposure to product).  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 11 Mar 2021, prior to the onset of the events, the patient administered the first of two planned vaccine doses of mRNA-1273 (Batch Number: unknown) in the left arm of a 21-year-old female patient for prophylaxis of COVID-19 infection.  On 11 Mar 2021, when needle was put in, liquid leaked out probably due to needle not being tightened on hub of vaccine, and the nurse experienced occupational exposure.  Action taken with mRNA-1273 in response to the event was unknown.    The outcome of the event, experienced occupational exposure, was recovered on 11 Mar 2021.; Reporter's Comments: This report refers to a case of Occupational exposure to product for mRNA-1273, lot # Unknown, with no associated AEs.; Sender's Comments:  MOD21-050022:Nurse case
Patient is allergic to cats, had tightness in chest, unable to breathe. Took a benadryl- it went away, eyelids was swollen. Sx did improve- eyelids are still swollen. Received #2 COVID 1/19/21 at 8am. Had a dental appt that afternoon for extraction, given Lidocaine w/out Epi, took Ibuprofen after visit. Reports acute onset chest tightness, SOB, audible wheezing at 5pm (approx 9 hrs post vaccine), then felt anxious. Took Benadryl 25mg and started feeling better in 20 min with resolution of wheezing and chest tightness after 1 hour. Also reports left eye swelling the same evening that has gradually decreased, now only mild with itching. Had similar eye swelling, however bilateral, after first vaccine dose. No SOB or wheezing noted since eve of 1/19/21. Denies hx asthma. NKDA. Allergic to cats. Denies swelling of lips, tongue, throat or rash. Reports feeling well today. Denies Covid-like sxs.
Rash/inflammation/redness at injection site roughly the size of a small fist. Jan 4- Jan 7  Rash decreased with time and was just a big red mark (roughly bigger fist) that also carried some physical heat-not like the rest of my arm.  No sign of rash or redness by Jan 8  Through Dec 27-first week of Jan I seem to have felt nauseated but comes and goes in waves.
Vaccines 06/15/2005 - c/o right deltoid site pain, 06/15/2005 pm.  06/16/ - seen in office with positive gastroemesis, hamstring tenderness.  Blood work done to rule out myositis.  06/17 - pain improving, fever 101.7 in am, 97.4 at time of visit, lyme and EBV titers normal was well.
PATIENT WAS GIVEN A PEDIATRIC DOSE OF HEPATITIS A INSTEAD OF ADULT HEP A.  PATIENT INFORMED.  SHE WILL COME BACK TO GET CORRECT DOSE.
Following Recieving vaccines, patient  passed out in  lobby while making  next OV apt. pt was sat in a chair and  given water. MD was notified. pt was  brought back to Exam Room for MD when  he passed out twice on the way to exam ROOM...
Began experiencing numbness/tingling in right hand and arm approximately 20-25 minutes after receiving vaccine. Nurse and pharmacist went to monitor more closely.  Began to feel flushed, lightheaded, sweating.  SpO2 99. Dr ordered 25mg diphenhydramine po.  Placed in wheel chair and taken to ER for further observation.
Information has been received from a physician via a company representative referring to a male patient of unknown age. Information about concurrent condition, medical history, drug reactions/allergies and concomitant medication were unknown. On an unknown date in 2016, the patient was sent to an unspecified pharmacy to receive a flu vaccine, but the patient was confused and thought he was possibly vaccinated with a dose of ZOSTAVAX (dose, route, lot # and expiration date were unknown) for prophylaxis. The physician was not quite sure if the patient even received ZOSTAVAX. On an unknown date in 2016, the patient developed "Guillain-Barre" after possibly receiving ZOSTAVAX. The patient sought medical attention by seeing physician. And then the patient was "hospitalized in an unspecified nursing home" for 6 months. The patient was received treatment for the event. It was unknown the specific dates the patient went into the unspecified nursing home. The patient was currently out of the nursing home. The outcome of Guillain-Barre syndrome was reported as recovered. The causality assessment between the event and ZOSTAVAX was not reported. Upon internal review, "Guillain-Barre" was determined to be medically significant and the physician considered the event to be disability and life-threatening. Additional information has been requested.
Information has been received from a physician concerning a 6 year and 10 month old female who on 23-SEP-2006 was vaccinated SQ with a second dose of Varivax (lot# 654030/0913F). On 23-SEP-2006 the patient developed red "hardening" at the injection site. It was "6 inches in diameter", "looked like a mosquito bite", and was "painful to the touch". The skin surrounding this area was also red. "After 7 day", on 29-Sep-2006, the patient recovered. Additional information has been requested.
Mom called and stated "my child had 5 shots 2 days ago and he's been running a high temp since the evening of the day he got them, his temp right now is 105.5. I have him in a cool bath and have been giving him Tylenol and Motrin alternatively every 4 hrs".
Student developed fatigue, body aches, vomiting x 1 and fever several hours after vaccine and into the next day.
I took pain killer medicines at home in the evening after vaccination in the morning (May 22, 2021).  However, I was having heart problem that day around at least 15 minutes after my second vaccination.  My heart felt stretching and beating too fast.  I didn't report at that time because my Lyft ride just arrived at the same time and I decided to take the ride back home.  My heart was  hurting for two days.  I also developed light fever around before midnight that same day of vaccination but recovered the following day through medicine and rest.
Client developed pins/needles type pain, around waist that traveled to behind knees by PM on 1/25/14. Eased since then with use of Ibuprofen. Was told by friend he had YE-ALD and should go to the ED if developed weakness. Has appt tomorrow with his PCP. Has tingling around ankles now only.
My body has very high temperature around 102 and fever. My muscles hurt all over my body. My body gets chills and I have missed work for almost 2 days now. I also feel cold.
Flu like symptoms, stayed in bed. Swelling, warm, large red area around injection site. Approximately 2.5 inches in diameter.
Received Tdap and MCV, and 1ast GARDISIL. Shortly afterwards was feeling bad, her throat hurt, very clammy, PO 100 degree F, P 101, respiratory and cardiovascular (N). Lay down symptoms eventually started to resolve and syncope recovered. Given BENADRYL because of throat as precaution. 20 minutes vital stable.
"Funny feeling" around mouth and extended down right side of neck beginning within 10 min after injection. Symptoms lasted for several hours particularly around mouth. Patient did no treatment, did report to primary care physician at next regularly scheduled appointment.
unusual and unwanted side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (unusual and unwanted side effects) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (unusual and unwanted side effects). At the time of the report, ADVERSE EVENT (unusual and unwanted side effects) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
I had severe pain in my right arm and upper back directly between my shoulder blades. Also had extreme dizziness and almost felt like I was having a hot flash. Witnesses say my cheeks became flushed as well.
Arm pain near site of shot; feverish; exhaustion; chills; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on 01Apr2021 at 10:45 (at the age of 26-years-old), as a single dose for COVID-19 immunisation. Medical history and concomintant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced arm pain near site of shot, feverish, exhaustion and chills. The clinical outcome of the events arm pain near site of shot, feverish, exhaustion and chills was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Shivering; Fever; Cough; This case was reported by a consumer via other manufacturer and described the occurrence of shivering in a male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   Co-suspect products included MODERNA VACCINE AGAINST COVID-19 for prophylaxis and lenvatinib mesilate (Lenvima) for hepatic cancer.   Concurrent medical conditions included increased blood pressure (started in August 2021 and not recovered), constipation (started in August 2021 and not recovered), abdominal bloating (started in August 2021 and not recovered), chest pain (knot in the middle of chest/6 out of 10 pain level/at times, after a meal"), stomatitis (started in August 2021 and not recovered), back pain, abdominal pain and hepatic cancer.   On an unknown date, the patient received Influenza vaccine Quadrivalent 2020-2021 season and MODERNA VACCINE AGAINST COVID-19. On 30th July 2021, the patient started Lenvima at an unknown dose and frequency. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced shivering, fever and cough. The action taken with Lenvima was unknown. On an unknown date, the outcome of the shivering, fever and cough were recovered/resolved.   It was unknown if the reporter considered the shivering, fever and cough to be related to Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were reported as follows: The age at vaccination was not reported. The patient received booster of Moderna vaccine and Flu vaccine had shivering, ever,cough but resolved after a day. The patient continued taking 8 mg daily per MD (off label starting dose and different from prescription (12 mg daily) as reported on 12th August 2021. After start of therapy, increase in blood pressure- improved; constipation or stomach bloating - on and off since last report. New report of  occasional knot in the middle of chest/6 out of 10 pain level/at times, after a meal, stomatitis, on and off lower back pain, abdominal pain (affecting night sleep)- MD aware and advised patient to miss one dose and take Lenvima in the morning (night sleep- improved), prescribed magic mouthwash for relief of stomatitis, and ordered Computed tomography scan on 25th AUgust 2021. The patient contact details were not reported hence follow up not possible.
The pt experienced numbness in the left arm after receiving the TD booster. She went to the school nurse the following day stating she had no feeling in the arm. She was advised to go to the MD. By the following day everything was fine.
Injection site arm sore/Injection site arm tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site arm sore/Injection site arm tender) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O12120A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE PAIN (Injection site arm sore/Injection site arm tender). At the time of the report, VACCINATION SITE PAIN (Injection site arm sore/Injection site arm tender) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Information has been received from a RN concerning a 5 year old male who on 25May99  was vaccinated with a dose of varicella virus vaccine live. On 16Oct2003 the pt presented to the office with a vesicular rash of a moderate number of lesions in generalized dissemination. No other symptoms were noted. No treatment was required. Unspecified medical attention was sought.  There was no product quality complaint involved. No other information was available. Additional information has been requested.
Information has been received from a nurse concerning a 19 year old female patient with allergic to erythromycin who on 19-MAY-2010 was vaccinated with a third 0.5 ml dose of GARDASIL (lot number 665768/1377Y) IM in the ventrogluteal area. Concomitant therapy included MICROGESTIN. The patient tensed up during administration and might not have received the full dose because some of the vaccine came out. The patient also felt light headed but the patient did not eat on the day and took a vitamin on an empty stomach. The patient mentioned GARDASIL injection previously "hurt her" and that was the reason why she did not want to get the vaccine at the recommended administration areas. It was unknown the area the patient received the previous dose or which dose, whether it was the first or second dose. No lab studies performed. On an unspecified date, the patient had recovered. Additional information has been requested.
4-16-04: babysitter brings her into clinic today after spoke to mother this am, babysitter has had child overnight, states arm was tender yesterday and last night, and swelling was up to shoulder. Babsitter states she has been giving tylenol to keep child from running a temp b/c has had a history of febrile seizures in the past. Babysitter states no fever noted but arm became red, swollen and tender yesterday. Babysitter states swelling has decreased and not as tender as was last night. Upon exam by RNs noted a large area around 3 inch long and 2" below acromion process on left upper arm. Also noted erythema, firmness and cellulitis in mid portion of affected area. Child was playful and swinging arms bilaterally today. Instructed babysitter to continue tylenol as affected area fell warm to touch and also give benadryl. Cool compresses to site today 24hours and warm compresses tomorrow 24hours. Babysitter states child will be at home with mother tomorrow. Will call and follow up on appearance of site tomorrow. Severe localized reaction to DTaP, instructed babysitter that child should not have any futher Td. Also called and left message on home phone for mother and will also attempt to speak to mother tomorrow. 4/17/04: Unable to reach mother at home, spoke with babysitter again, said arm looking better, thinks cool compresses helped, mother picked up earlier. 4/19/04: spoke with mother this am, said child was doing better today, still has around 2 inch area that is red. Discussed with mother the fact reaction was classic Td reaction. Informed mother that would not booster with Td. Have a call into MD and will notify if find out anything different. 4/26/04: spoke with mother this am, symptoms basically resolved but still as small discolored area on arm.
Severe flare ups rheumatic arthritis. Involving hands, wrists, neck, jaw and legs
administered the liquid adjuvant portion only of Shingrix; administered the liquid adjuvant portion only of Shingrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 50-year-old male patient who received Herpes zoster (Shingrix) (batch number 9AT7A, expiry date 06-AUG-2024) for prophylaxis.   On 19-JUN-2023, the patient received the 1st dose of Shingrix. On 19-JUN-2023, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: administered the liquid adjuvant portion only of Shingrix) and inappropriate dose of vaccine administered (Verbatim: administered the liquid adjuvant portion only of Shingrix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 29-Jun-2023 Department supervisor reported that the patient was administered the liquid adjuvant portion only of Shingrix and it was not reconstituted with the lyophilized component.  At the time of reporting a repeat dose has not been administered. The Vaccine Administration Facility was the same as Primary Reporter. The reporter gave permission for follow-up. This is 1 of 3 linked patients, reported by same reporter. The patient received only liquid adjuvant portion of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.; Sender's Comments:  US-GSK-US2023090170:Same reporter US-GSK-US2023090171:Same reporter
Patient received Pfizer vaccine after having received the Moderna vaccine four weeks prior. No immediate side effects were noted. She was clinically well when she left the vaccine clinics. She was informed that the Pfizer dose administered today would count as her second Covid vaccine and that she did not need to receive a second Moderna shot.
This spontaneous report was received from a physician via company representative refers to a male patient of unknown age. Medical history was not reported. In approximately July 2012 (also reported as two years ago) the patient was vaccinated with ZOSTAVAX (lot number, expiration date, routed, and dosage were not reported) for prophylaxis. Concomitant therapy was not reported. The reporter informed that approximately in 2012 (also reported as two weeks later) the patient developed pericarditis. The physician was not sure if the patient developed pericarditis attack as a result of the vaccinated with ZOSTAVAX vaccine, he stated that there were other factors and other vaccines (unspecified). The outcome of the event was unknown. Additional information has been requested.
PT felt dizzy and about to faint, was put in a chair, right after she lost her consciousness completely, start generalized shaking episodes for few seconds, wake up very nauseous, tried to throw up so  many times, did not remember what happened beside feeling dizzy before the accident, pt was given im shot for vomiting, and felt better, pt was sent to ER, for further evaluation